Skip to main content
. 2006 Dec;2(4):435–445. doi: 10.2147/tcrm.2006.2.4.435

Table 2.

Toxicities associated with the combination of erlotinib and gemcitabine in the NCIC Phase III study

Toxicity Gemcitabine plus erlotinib (%) n=282 Gemcitabine plus placebo (%) n=280
Any Grade 3/4 Any Grade 3/4
Rash 72 6 29 1
Diarrhea 56 6 41 2
Neutropaenia 31 25 28 26
Thrombocytopaenia 64 10 66 12
Infection 43 17 34 16
Stomatitis 23 <1 14 0
Pneumonitis 2 2 1 <1
Fatigue 89 15 86 15
Dehydration 8 3 10 5

Abbreviations: NCIC, National Cancer Institute of Canada.

HHS Vulnerability Disclosure